Clinical Trial Update: XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for XELOX (Xeloda + Eloxatin) in advanced/metastatic colorectal cancer, encompassing Phase 2 and Phase 3 data; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• XELOX (capecitabine + oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Odense University Hospital | Conditions: C04.588.274.476.411.307 | Phase 2, Phase 3 | Status: COMPLETED